Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Immunotherapy, Active × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2 Gastrointestinal 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1 Breast 1

Conditions

Interventions

Radiotherapy 198 Cyclophosphamide 198 Doxorubicin 190 Temozolomide 169 Ifosfamide 112 Filgrastim 101 Etoposide 94 Imatinib Mesylate 91 Vincristine 86 Bevacizumab 77 Gemcitabine 76 Irinotecan 75 Magnetic Resonance Spectroscopy 69 pembrolizumab 65 Radiation 61 Carboplatin 59 pazopanib 56 Methotrexate 55 fludarabine phosphate 53 Cisplatin 53 Nivolumab 51 Specimen Handling 49 Peripheral Blood Stem Cell Transplantation 48 Trabectedin 44 Docetaxel 44 Biopsy 44 Busulfan 43 Melphalan 42 fludarabine 39 Paclitaxel 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03357315 2019-09-12

Mix Vaccine for Metastatic Sarcoma Patients

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡